Keyword

poly-ICLC

Description: Poly-ICLC is a synthetic double-stranded RNA-based pharmaceutical compound used as an immune-stimulating adjuvant in cancer research and therapy.
Wikidata ID: wiki/Q7226111
OpenAlex ID: keywords/poly-iclc
2015 · Alfonso R. Sánchez-Paulete, Francisco J. Cueto, et al. · Cancer Discovery · 527
2014 · Madhav V. Dhodapkar, Mario Sznol, et al. · Science Translational Medicine · 393
2010 · Lis R.V. Antonelli, Antonio Gigliotti Rothfuchs, et al. · Journal of Clinical Investigation · 313
2011 · Marina Caskey, François Lefebvre, et al. · The Journal of Experimental Medicine · 293
1981 · Marinos C. Dalakas, W. King Engel · Annals of Neurology · 291
2014 · Karen AO Martins, Sina Bavari, et al. · Expert Review of Vaccines · 251
2014 · Rachid Ammi, Jorrit De Waele, et al. · Pharmacology & Therapeutics · 205
2011 · C. Trumpfheller, M. P. Longhi, et al. · Journal of Internal Medicine · 178
2018 · Chrisann Kyi, Vladimir Roudko, et al. · Clinical Cancer Research · 149
2020 · Nina Bhardwaj, Philip A. Friedlander, et al. · Nature Cancer · 147
2017 · Shikhar Mehrotra, Carolyn D. Britten, et al. · Journal of Hematology & Oncology · 146
2020 · Sabine Mueller, Jared M. Taitt, et al. · Journal of Clinical Investigation · 131
1996 · W E Fogler, K Volker, et al. · The Journal of Immunology · 130
Works count: 400
Citation count: 11,050
Year
Topic
Type